Kameel Antami, Ph.D., is a Senior Scientist at Pfizer, specializing in ADC drug-linker process development and flow chemistry. With extensive experience in process design, scale-up, and optimization, Kameel has also contributed to research and development in microfluidic platforms and material science. They have published multiple first-author papers and held positions at renowned institutions including North Carolina State University and L'Institut de chimie de la matière condensée de Bordeaux. Kameel's innovative work in carbon dioxide removal technologies and cancer screening continues to impact the scientific community.
This person is not in the org chart
This person is not in any teams
This person is not in any offices